ELRIG

We hear from the experts as they tell us their thoughts on the biggest challenges faced in drug discovery. 

What are the biggest challenges in drug discovery?

Kevin Doherty, Professor & MacLeod-Smith Chair of Biochemistry, University of Aberdeen tells us about some of the current limitations of current therapies for type 1 diabetes, and how his research is helping to address these issues.

Therapies for Type 1 Diabetes - Current Limitations and Novel Approaches

Jon Moore, CSO at Horizon Discovery talks CRISPR-Cas9 and his experiences with technically demanding whole genome negative-selection screens. 

Identifying novel synthetic lethal targets with CRISPR-Cas9 

Kevin Doherty, Professor & MacLeod-Smith Chair of Biochemistry, University of Aberdeen, tells us about some of the limitations of current therapies for type 1 diabetes.

What are the limitations of current therapies for type 1 diabetes?

Chas Bountra, Professor of Translational Medicine, Oxford Structural Genomics Consortium, University of Oxford, tells us about some of today's biggest drug discovery challenges.

What are some of the biggest challenges of drug discovery today?

Jon Moore, CSO at Horizon Discovery, gives us his view of the 'essentialome'

ELRIG

Home

Videos

Playlists

About

Keep up to date with all your favourite videos and channels.

Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.